S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer

NCT00580359 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

96

Enrollment

OTHER_GOV

Sponsor class

Conditions

Stomach Neoplasms

Interventions

DRUG: S-1, capecitabine

Sponsor

National Cancer Center, Korea